Trial Profile
Cardiac safety of a granisetron transdermal system in the treatment of chemotherapy-induced nausea and vomiting.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2011
Price :
$35
*
At a glance
- Drugs Granisetron (Primary) ; Granisetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions
- Sponsors ProStrakan
- 22 Jun 2011 New trial record